Healthcare >> CEO Interviews >> October 26, 2004
LEONARD KRUIMER has been Chief Financial Officer of Crucell NV since he
joined the company (formerly IntroGene) in 1998. Mr. Kruimer led the
company's mezzanine financing round in 1999, oversaw the IPO in 2000 and
is responsible for investor relations. From 1996 to 1998 he was an
interim manager at various companies including Pepsico and Royal
Boskalis Westminster. From 1993 to 1995, Mr. Kruimer was Managing
Director, Continental Europe at GE Capital/TIP Europe. Prior roles
included Managing Director of Kwik-Fit Europe and Finance Director at
Continental Can Europe. He was a consultant with McKinsey & Company and
an auditor with Price Waterhouse & Co. Mr. Kruimer holds an MBA from the
Harvard Graduate School of Business Administration, and graduated from
the University of Massachusetts, Amherst. He is a CPA in New York State. Profile
Mr. Kruimer: Crucell is an infectious disease company. We target a
number of infectious diseases with vaccines and antibodies that
